Hot Stocks to Watch in the U.S. and Canada
28 Agosto 2017 - 10:29AM
Dow Jones News
By Cara Lombardo
Companies with shares expected to trade actively in Monday's
session include Kite Pharma Inc. (KITE), Ixys Corp. (IXYS), and EOG
Resources Inc. (EOG).
Gilead Sciences Inc.(GILD) said Monday it will buy Kite Pharma
for roughly $11 billion, sending Kite shares up roughly 29%
premarket. Kite's primary drug, which harnesses the body's immune
system to fight lymphoma and other blood cancers, is up for
approval in the U.S. and Europe. Gilead will pay $180 per Kite
share, representing a 29% premium over Kite's Friday closing
price.
Shares in semiconductor-maker Ixys are up 41% premarket after
Littelfuse Inc.(LFUS) announced plans to buy it for $750 million.
Littelfuse said it was making the purchase to bolster its presence
in the power control and industrial markets and the combined firm
would generate about $1.5 billion of revenue a year.
EOG is one of the oil producers that has suspended operations in
southern Texas as Tropical Storm Harvey dumps heavy rains and
floods the Houston area. Five deaths believed to be storm-related
had been reported in the Houston area as of Sunday evening. The
storm has also taken almost 15% of the U.S. refinery capacity
offline. EOG shares are down 0.8% to $83.82 premarket.
Write to Cara Lombardo at cara.lombardo@wsj.com
(END) Dow Jones Newswires
August 28, 2017 09:14 ET (13:14 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
KITE PHARMA, INC. (NASDAQ:KITE)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
KITE PHARMA, INC. (NASDAQ:KITE)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Kite Pharma, Inc. da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Kite Pharma, Inc. (MM)